Primary imatinib resistance in chronic myeloid leukemia patients in a developing country: BCR-ABL kinase domain mutations or BCR-ABL independent mechanisms?

Yap, E; Tumian, NR; Azma, RZ; Sharifah, NA; Salwati, S; Hamidah, NH; Elias, MH; Wong, CL

Yap, E (reprint author), Univ Kebangsaan Malaysia, Med Ctr, Dept Med, Haematol Unit, Bangi, Malaysia.

MALAYSIAN JOURNAL OF PATHOLOGY, 2017; 39 (2): 107

Abstract

Clinical resistance to imatinib (IM) in chronic myeloid leukemia (CML) carries adverse consequences. We investigated 22 CML patients who developed IM-......

Full Text Link